Sabrina Carpenter Makes Her First Sisterly Arrest With Elle and Dakota Fanning
Category: general
Met Gala 2026: Jeff Bezos and Lauren Sánchez Bezos’ Roles Revealed
Jeff Bezos and Lauren Sánchez Bezos have prime billing for the 2026 Met Gala. Indeed, the Amazon founder and his wife are the primary donors helping to fund “Costume Art,” the spring 2026.
Singer D4vd is considered a suspect in death investigation of 15-year-old Celeste Rivas, source says
The singer D4vd is considered a suspect in the death investigation of 15-year-old Celeste Rivas, a source told ABC News.
9 Reasons Your Property Taxes Keep Going Up Even Though You’re A Senior
Many retirees assume that once they reach a certain age, property taxes will level off or decrease. After all, seniors often qualify for exemptions or.
Gold Slips Toward $4,000 As Four-Day Pullback Tests Key Support Zone
Gold Slips Toward $4,000 As Four-Day Pullback Tests Key Support Zone
New AI-Powered Cancer Drugs Fuel Share Rally Of Korea’s Voronoi, Minting A New Billionaire
The post New AI-Powered Cancer Drugs Fuel Share Rally Of Korea’s Voronoi, Minting A New Billionaire appeared on BitcoinEthereumNews.com. South Korea’s biotech sector is having its moment. Investor optimism about the pipeline of cancer drugs being developed by biotech company Voronoi has fueled a rally in its shares, which are up by 190% so far this year. The stock surge has minted the country’s newest billionaire in Hyuntae Kim, the company’s CEO. Kim, 49, is Voronoi’s largest shareholder with a 35% stake worth $1 billion. (His wife, Kim Dae-yeon, has an additional holding of close to 1%.) The 4.3 trillion won ($2.9 billion) market cap company, which had no revenue last year, reported sales of a modest 7.5 billion won ($5.1 million) for the first nine months of 2025, while losses widened by 62% to 38.4 billion won. Despite the company being in the red, investors are betting that its two most promising cancer drug candidates—VRN10 and VRN11—will turn things around. VRN10 is designed to block a protein called human epidermal growth factor receptor 2, or HER2, which causes aggressive growth in certain breast cancers. The VRN11 aims to inhibit the epidermal growth factor receptor, or EGFR, which is commonly mutated in non-small cell lung cancer and causes abnormal cell growth. Phase 1 clinical trials of both drugs commenced in the first quarter of this year and are expected to finish around mid-2026. “VRN11 is progressing step by step toward validation,” Hyunsoo Ha, a researcher at Yuanta Securities, said in a report published this month. “VRN10 is also on track,” he added. Based in Incheon, west of Seoul, Voronoi uses a proprietary AI platform called Voronomics that “revolutionizes the drug development process, enabling the rapid discovery of development candidates,” the company says on its website. In September, Voronoi had signed a $14.5 million technology transfer deal with New York-based Anvia Therapeutics for its VRN04 experimental drug that targets RIPK1,…
Attorney: AG’s office is ‘victim-blaming’ in prison sex assault case
Lashanda Gregory’s attorney claimed the AG’s office had engaged in ‘victim-blaming’ after she sued for being sexually assaulted in prison.
Education Department takes a major step forward in the Trump administration’s plans to dismantle it
The U. S. Education Department is handing off some of its biggest grant programs to other federal agencies as the Trump administration accelerates its plan to shut down the department.
House Votes to Release Epstein Files, Trump & MBS Asked About Khashoggi, More
Listen for the latest from Bloomberg News
Watch: Video of Shedeur Sanders’ home getting ransacked by burglars goes viral as Browns QB loses goods worth $200,000
Cleveland Browns rookie quarterback Shedeur Sanders had a tough night on Sunday. While he made his regular-season debut against the Baltimore Ravens, his home was broken into.